Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

LUNAI BIOWORKS INC. (LNAI) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

LUNAI BIOWORKS INC. (LNAI), most recent 12 months reported: revenue $51.99K, net loss $3.56M, free cash flow -$5.29M. From SEC filings. Others in Pharmaceutical Preparations: ASPIRE BIOPHARMA HOLDINGS, INC. · Actinium Pharmaceuticals, Inc. · AVALO THERAPEUTICS, INC. · SILO PHARMA, INC. · ALTIMMUNE, INC. · NEONC TECHNOLOGIES HOLDINGS, INC. · Impact BioMedical, INC. · Lyell Immunopharma, Inc.

Stock screener

Watchlist